Chief Scientific Officer
Translate Bio, Massachusetts
Beata Sweryda-Krawiec, Ph.D., is the Associate Director of Analytical and Formulation Development at Tarveda Therapeutics in Watertown, MA. She is experienced in large pharma and smaller biotechs by leading projects related to formulation, form selection, solid-state characterization for small molecules, drug conjugates (ADC), nucleotides and peptides. Her industry experience includes leading teams and working across different functions developing preclinical and clinical formulations including self-assemble nanoparticles, sustained-release injectables, polymeric nanoparticles, prodrugs, and conjugates.
Beata’s experience spans across all stages of drug development including lead selection, phase appropriate formulation development, analytical transfer activities related to the development and manufacturing of DS/DP for parenteral formulations.
Beata earned her doctorate in inorganic chemistry/material science from Texas Christian University, Fort Worth, TX and continued her academic research as a postdoctoral fellow at the Center for Advanced Material Processing, Potsdam, NY and the Bioengineering Department at Clemson University, Clemson, SC.
Beata entered the pharmaceutical industry as a Senior Scientist at Novartis, East Hanover, NJ, and continued her industry career at Amgen, Cambridge, MA. About ten years ago, she shifted her interest toward nanomedicine, and the development of advanced drug delivery systems at biotech.
Beata authored several publications and presentations and contributed to several papers and patents.
Tuesday, October 27, 2020
3:30 PM – 4:30 PM ET
Wednesday, October 28, 2020
9:00 AM – 10:00 AM ET